BX Swiss TOP 30 CHF 119469669 / DE000SL0CLV3
1’270.79
Pkt
9.69
Pkt
0.77
%
22:49:53
Anzeige
| Kurse + Charts + Realtime | Nachrichten | Listen | Info | zugeh. Wertpapiere | |
|---|---|---|---|---|---|
| Snapshot | Chart (gross) | Marktberichte | enthaltene Werte | GV-Termine | Strukturierte Produkte |
| Historisch | Chartvergleich | Analysen | Top/Flop | Dividenden | |
| Realtime Liste | Marktkapitalisierung | ||||
Kurse + Charts + Realtime
Nachrichten
Info
zugeh. Wertpapiere
Analysen zu BX Swiss TOP 30 CHF-Werten
| 24.09.24 | Richemont Overweight | JP Morgan Chase & Co. | |
| 23.09.24 | Nestlé Sector Perform | RBC Capital Markets | |
| 20.09.24 | Richemont Buy | Jefferies & Company Inc. | |
| 20.09.24 | Givaudan Hold | Deutsche Bank AG | |
| 20.09.24 | Nestlé Neutral | UBS AG | |
| 20.09.24 | Richemont Buy | Goldman Sachs Group Inc. | |
| 19.09.24 | Zurich Insurance Overweight | Barclays Capital | |
| 19.09.24 | Zurich Insurance Overweight | Barclays Capital | |
| 19.09.24 | Swiss Re Equal Weight | Barclays Capital | |
| 19.09.24 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.09.24 | ABB Sector Perform | RBC Capital Markets | |
| 18.09.24 | Givaudan Underperform | Jefferies & Company Inc. | |
| 18.09.24 | Givaudan Buy | Goldman Sachs Group Inc. | |
| 18.09.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 18.09.24 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
| 18.09.24 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 17.09.24 | Givaudan Neutral | UBS AG | |
| 17.09.24 | Givaudan Neutral | UBS AG | |
| 17.09.24 | Givaudan Underperform | Jefferies & Company Inc. | |
| 17.09.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 17.09.24 | Richemont Overweight | Barclays Capital | |
| 16.09.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 16.09.24 | Roche Neutral | UBS AG | |
| 13.09.24 | Swiss Re Sector Perform | RBC Capital Markets | |
| 13.09.24 | Givaudan Neutral | UBS AG | |
| 13.09.24 | Roche Sell | Deutsche Bank AG | |
| 12.09.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 11.09.24 | Novartis Buy | UBS AG | |
| 11.09.24 | ABB Neutral | JP Morgan Chase & Co. | |
| 10.09.24 | Roche Neutral | UBS AG | |
| 10.09.24 | Roche Sell | Goldman Sachs Group Inc. | |
| 10.09.24 | Richemont Outperform | Bernstein Research | |
| 10.09.24 | Roche Hold | Deutsche Bank AG | |
| 09.09.24 | Roche Underweight | JP Morgan Chase & Co. | |
| 09.09.24 | Roche Neutral | UBS AG | |
| 09.09.24 | Givaudan Neutral | UBS AG | |
| 09.09.24 | UBS Overweight | JP Morgan Chase & Co. | |
| 09.09.24 | Richemont Overweight | Barclays Capital | |
| 09.09.24 | Nestlé Equal Weight | Barclays Capital | |
| 06.09.24 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |